All storiesMRK.DE in storiesMRK.DE stock

Merck KGaA in 1 story

The narratives MRK.DE currently appears in, with its side and exposure in each.

Bull side

0 stories

No bull-side stories for MRK.DE yet.

Bear side

1 story

America Imports the World's Drug Prices
MRK.DE in “America Imports the World's Drug Prices”
StableExposure: not rated yet
US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Merck KGaA relies on patented specialty medicines such as Mavenclad and Bavencio whose global pricing corridors could tighten under US reference pricing.

Bear side

1 story

America Imports the World's Drug Prices
MRK.DE in “America Imports the World's Drug Prices”
StableExposure: not rated yet
US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Merck KGaA relies on patented specialty medicines such as Mavenclad and Bavencio whose global pricing corridors could tighten under US reference pricing.